Submitted by Nicola-Swanborough on Mon, 23/09/2019 - 15:49
Epilepsy Society's medical director Professor Ley Sander has cautiously welcomed a decision by the European Commission to approve Epidyolex in the treatment of two severe childhood epilepsies.
Submitted by Nicola-Swanborough on Tue, 03/09/2019 - 11:17
Why NICE is right to be cautious about recommending medicinal cannabis for two childhood epilepsy syndromes. Our medical director, Professor Ley Sander writes.
Submitted by rhiannon-arden on Tue, 30/07/2019 - 09:23
Epidyolex, an oral solution of cannabidiol, has been recommended for approval for use as an add-on therapy for seizures.
Submitted by Nicola-Swanborough on Thu, 01/11/2018 - 10:48
As of this morning (1 November), specialist doctors in the UK can now prescribe cannabis-based medicines to patients with a limited number of conditions. This includes children with severe epilepsy syndromes.
Submitted by Nicola-Swanborough on Fri, 12/10/2018 - 16:06
Specialist doctors in the UK will be able to prescribe cannabis-based medicines from 1 November, now a change in the law has been laid in Parliament.
Submitted by Nicola-Swanborough on Fri, 27/07/2018 - 17:55
A government decision to relax the licensing laws around cannabis-derived medicinal products has been welcome by Epilepsy Society.